These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 22617343)
21. [Intragenic deletions of NRXN1: three new case reports and a review of the phenotype]. Galán-Sánchez F; Esteban-Cantó V; Blaya-Fernández P; Jadraque-Rodríguez R; Manchón-Trives I; Alcaraz-Más L Rev Neurol; 2015 Mar; 60(5):215-8. PubMed ID: 25710691 [TBL] [Abstract][Full Text] [Related]
22. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family. Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496 [TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs. Chen X; Shen Y; Zhang F; Chiang C; Pillalamarri V; Blumenthal I; Talkowski M; Wu BL; Gusella JF Am J Hum Genet; 2013 Mar; 92(3):375-86. PubMed ID: 23472757 [TBL] [Abstract][Full Text] [Related]
24. NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series - further understanding of the relevance of NRXN1 to neurodevelopmental disorders. Curran S; Ahn JW; Grayton H; Collier DA; Ogilvie CM J Mol Psychiatry; 2013; 1(1):4. PubMed ID: 25408897 [TBL] [Abstract][Full Text] [Related]
25. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Vaags AK; Lionel AC; Sato D; Goodenberger M; Stein QP; Curran S; Ogilvie C; Ahn JW; Drmic I; Senman L; Chrysler C; Thompson A; Russell C; Prasad A; Walker S; Pinto D; Marshall CR; Stavropoulos DJ; Zwaigenbaum L; Fernandez BA; Fombonne E; Bolton PF; Collier DA; Hodge JC; Roberts W; Szatmari P; Scherer SW Am J Hum Genet; 2012 Jan; 90(1):133-41. PubMed ID: 22209245 [TBL] [Abstract][Full Text] [Related]
26. CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. Nag A; Bochukova EG; Kremeyer B; Campbell DD; Muller H; Valencia-Duarte AV; Cardona J; Rivas IC; Mesa SC; Cuartas M; Garcia J; Bedoya G; Cornejo W; Herrera LD; Romero R; Fournier E; Reus VI; Lowe TL; Farooqi IS; ; Mathews CA; McGrath LM; Yu D; Cook E; Wang K; Scharf JM; Pauls DL; Freimer NB; Plagnol V; Ruiz-Linares A PLoS One; 2013; 8(3):e59061. PubMed ID: 23533600 [TBL] [Abstract][Full Text] [Related]
27. Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder. Chaudhry A; Noor A; Degagne B; Baker K; Bok LA; Brady AF; Chitayat D; Chung BH; Cytrynbaum C; Dyment D; Filges I; Helm B; Hutchison HT; Jeng LJ; Laumonnier F; Marshall CR; Menzel M; Parkash S; Parker MJ; ; Raymond LF; Rideout AL; Roberts W; Rupps R; Schanze I; Schrander-Stumpel CT; Speevak MD; Stavropoulos DJ; Stevens SJ; Thomas ER; Toutain A; Vergano S; Weksberg R; Scherer SW; Vincent JB; Carter MT Clin Genet; 2015 Sep; 88(3):224-33. PubMed ID: 25131214 [TBL] [Abstract][Full Text] [Related]
28. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Zweier C; de Jong EK; Zweier M; Orrico A; Ousager LB; Collins AL; Bijlsma EK; Oortveld MA; Ekici AB; Reis A; Schenck A; Rauch A Am J Hum Genet; 2009 Nov; 85(5):655-66. PubMed ID: 19896112 [TBL] [Abstract][Full Text] [Related]
32. [Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays]. Wang L; Shi P; Ren H; Xue S; Kong X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1200-1204. PubMed ID: 36317203 [TBL] [Abstract][Full Text] [Related]
33. Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. Lionel AC; Tammimies K; Vaags AK; Rosenfeld JA; Ahn JW; Merico D; Noor A; Runke CK; Pillalamarri VK; Carter MT; Gazzellone MJ; Thiruvahindrapuram B; Fagerberg C; Laulund LW; Pellecchia G; Lamoureux S; Deshpande C; Clayton-Smith J; White AC; Leather S; Trounce J; Melanie Bedford H; Hatchwell E; Eis PS; Yuen RK; Walker S; Uddin M; Geraghty MT; Nikkel SM; Tomiak EM; Fernandez BA; Soreni N; Crosbie J; Arnold PD; Schachar RJ; Roberts W; Paterson AD; So J; Szatmari P; Chrysler C; Woodbury-Smith M; Brian Lowry R; Zwaigenbaum L; Mandyam D; Wei J; Macdonald JR; Howe JL; Nalpathamkalam T; Wang Z; Tolson D; Cobb DS; Wilks TM; Sorensen MJ; Bader PI; An Y; Wu BL; Musumeci SA; Romano C; Postorivo D; Nardone AM; Monica MD; Scarano G; Zoccante L; Novara F; Zuffardi O; Ciccone R; Antona V; Carella M; Zelante L; Cavalli P; Poggiani C; Cavallari U; Argiropoulos B; Chernos J; Brasch-Andersen C; Speevak M; Fichera M; Ogilvie CM; Shen Y; Hodge JC; Talkowski ME; Stavropoulos DJ; Marshall CR; Scherer SW Hum Mol Genet; 2014 May; 23(10):2752-68. PubMed ID: 24381304 [TBL] [Abstract][Full Text] [Related]
34. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556 [TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the NRXN1 gene in a Chinese autism cohort. Liu Y; Hu Z; Xun G; Peng Y; Lu L; Xu X; Xiong Z; Xia L; Liu D; Li W; Zhao J; Xia K J Psychiatr Res; 2012 May; 46(5):630-4. PubMed ID: 22405623 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Roberts JL; Hovanes K; Dasouki M; Manzardo AM; Butler MG Gene; 2014 Feb; 535(1):70-8. PubMed ID: 24188901 [TBL] [Abstract][Full Text] [Related]
37. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560 [TBL] [Abstract][Full Text] [Related]
38. Dual genetic diagnoses: Atypical hand-foot-genital syndrome and developmental delay due to de novo mutations in HOXA13 and NRXN1. Wallis M; Tsurusaki Y; Burgess T; Borzi P; Matsumoto N; Miyake N; True D; Patel C Am J Med Genet A; 2016 Mar; 170(3):717-24. PubMed ID: 26590955 [TBL] [Abstract][Full Text] [Related]
39. Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging. Jenkins AK; Paterson C; Wang Y; Hyde TM; Kleinman JE; Law AJ Mol Psychiatry; 2016 May; 21(5):701-6. PubMed ID: 26216298 [TBL] [Abstract][Full Text] [Related]
40. Chromosomal loss of 3q26.3-3q26.32, involving a partial neuroligin 1 deletion, identified by genomic microarray in a child with microcephaly, seizure disorder, and severe intellectual disability. Millson A; Lagrave D; Willis MJ; Rowe LR; Lyon E; South ST Am J Med Genet A; 2012 Jan; 158A(1):159-65. PubMed ID: 22106001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]